🇺🇸 FDA
Patent

US 9683235

Compositions for modulating Tau expression

granted A61KA61K31/711A61P

Quick answer

US patent 9683235 (Compositions for modulating Tau expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K31/711, A61P, A61P25/00, A61P25/08